相关实验视频
Updated: Jul 29, 2025

Generation of Murine Monoclonal Antibodies by Hybridoma Technology
Published on: January 2, 2017
抗病毒多克隆和单克隆抗体疗法的用途和挑战
Evi B Struble1, Jonathan M O Rawson2, Tzanko Stantchev3
1Division of Plasma Derivatives, Office of Plasma Protein Therapeutics CMC, Office of Therapeutic Products, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Silver Spring, MD 20993, USA.
包括多克隆和单克隆选项在内的抗病毒抗体疗法对于预防和治疗病毒性疾病和大流行至关重要. 本综述涵盖了它们的特性,开发和组合策略,以提高有效性.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 治疗方法 治疗方法
背景情况:
- 病毒性疾病对全球公共卫生构成重大风险,具有流行病潜力.
- 抗病毒抗体治疗对预防和治疗至关重要,特别是在健康紧急情况下.
研究的目的:
- 讨论多克隆和单克隆抗病毒抗体疗法.
- 突出其与治疗用途相关的生化和生理性质.
- 探索组合策略和新的开发方法.
主要方法:
- 关于抗病毒抗体疗法的现有文献的审查.
- 讨论抗体表征和疗效评估方法.
- 分析治疗应用中的好处和挑战.
主要成果:
- 多克隆和单克隆抗体作为抗病毒剂具有明显的优势.
- 在整个发育过程中,表征和强度评估至关重要.
- 组合疗法为改善结果提供了机遇和挑战.
结论:
- 抗病毒抗体是对抗病毒威胁的必不可少的工具.
- 进一步研究小说的表征和发展是有必要的.
- 优化组合策略可以提高治疗效率.
更多相关视频
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
13:14Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
相关概念视频
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Retrovirus Life Cycles
Tumor Immunotherapy
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Humoral Immune Responses